Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
Neda Stjepanovic, Jaume CapdevilaDepartment of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, SpainAbstract: Thyroid cancers are the most frequent neoplasms of the endocrine system and in the initial stages their prognosis is excellent. However, few therapeutic options are...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/multikinase-inhibitors-in-the-treatment-of-thyroid-cancer-specific-rol-a16433 |